Page Contents
Fred Hutch Cancer Center offers comprehensive care for chronic lymphocytic leukemia (CLL). We offer advanced therapies and new options available only through clinical trials.
Unlike most cancers, CLL is a long-term condition that may not need to be treated for many years. Many people with CLL do well without treatment for a long time. But in some cases, getting treatment right away is essential. To protect your health, it’s important to work with CLL experts who know how to get you the right care soon after diagnosis.
We understand the complex details that go into planning the right approach for each person, like whether you need treatment at all, and if so, what kinds of treatment you need and when. Our deep experience means the best care to control your disease or put it into remission.
Small lymphocytic lymphoma (SLL) is closely related to CLL. In SLL, cancer cells are found in the lymph nodes and spleen. In CLL, cancer cells are found in the blood and bone marrow. Most of the information in this treatment section about CLL also applies to SLL.
Chronic Lymphocytic Leukemia Care Tailored to You
You and your family are our top priority. At Fred Hutch Cancer Center, we offer comprehensive and compassionate care — personalized to you. You'll have access to the latest treatment options, clinical trials and supportive care services.
Your CLL Treatment Plan
The treatment plan we design for you depends on many things, including:
- Your CLL stage
- Any chromosome or gene changes in your leukemia cells (like a missing part of a chromosome or having an extra chromosome)
- If you have a change in the gene IgHV (immunoglobulin heavy-chain variable region gene)
- If you have symptoms
- Your age and general health
- How quickly your leukemia cells grow
- Your values, needs and preferences, like what type of treatment schedule works in your life and if you want to join a clinical trial
These factors guide decisions about which standard therapies and which clinical trials are the best match for you.
How We Treat CLL at Fred Hutch
Treatment looks different for different people. Fred Hutch offers all standard therapies and we tailor your treatment plan to you.
Some people with CLL can safely wait years, maybe even decades, to begin active treatment. In fact, some never need treatment at all. Patients who do not have symptoms or low blood counts are often on watchful waiting.
If your CLL is getting worse quickly or is higher risk, the standard therapy for most people is targeted therapy or immunotherapy. There are many ways to combine medicines to improve results. If you need active treatment, we choose, combine and schedule your therapies based on what works for CLL like yours. The goal of active treatment is to put your disease into long-term remission. When you aren’t in remission, the goals are to slow the disease and reduce any symptoms.
Some people with high-risk disease who have already tried other treatments have a blood or marrow transplant. Novel (new) therapies are available here, too. Because of recent advancements in treating CLL, chemotherapy is rarely used now.
Your care team makes sure you understand each type of treatment and all of your choices.
Watchful Waiting for CLL
If your CLL is low or intermediate risk, your physician may recommend watchful waiting.
This is also called observation or active surveillance. It means you and your physician closely monitor your health for any changes, like signs that your CLL is clearly getting worse.
During watchful waiting, you will visit your physician for exams and have blood tests on a regular schedule. The schedule depends mainly on your health. We also ask you about your preferences. Some people want to come in more often, especially in the early months after their diagnosis. Then, if their disease is stable, they get comfortable letting more time pass between visits.
In between scheduled visits, you are not on your own. We are here. If you notice health changes, we encourage you to call so we can check if you do need active treatment.
Research shows there is no benefit to starting treatment for CLL early. However, there are benefits to waiting until symptoms begin to bother you, your levels of blood cells get worse or there are other signs that the disease is progressing.
The main benefits of waiting include:
- You can keep living your life without much of a change. You will not have side effects from treatments you do not need.
- When you do need treatments later, they will still work just as well.
- Better options might be available in the future.
Even if you do not need treatment right now, we might have clinical trials that you want to think about. Some trials test new approaches (new drugs or new combinations of drugs) to care for people with low- or intermediate-risk CLL.
Targeted Therapy for CLL
Chemotherapy used to be the main treatment for CLL. Now, most people do very well with targeted therapies and immunotherapies. As result, chemotherapy has little to no role.
Targeted therapies are more exact than standard chemotherapy, which affects all fast-growing cells throughout the body. They work in one of three ways:
- They target a gene or protein that causes cancer growth.
- They damage cancer cells directly.
- They tell your immune system to attack certain cells. This is also called immunotherapy.
Your hematologist-oncologist will prescribe your targeted therapy and set your treatment schedule. Targeted therapies are usually given as a pill that you take at home. Some are given by infusion in repeating cycles. Liquid medicine is put into a vein through an intravenous (IV) line. This can be a line in your arm (peripheral venous catheter) or a port in your chest (central venous catheter).
You get infusions in a dedicated area of the Sloan Clinic. Cancer nurses who are experts in infusions will give you these treatments. They will also monitor you during the treatment. They respond to any medical issues that come up and help keep you comfortable.
We have several options that target different features of CLL. Some are used as first-line treatments. Some are saved and used after trying other treatments first. They can be used alone or with other medicines.
Options for Targeted Therapy
Examples of targeted CLL therapies include:
- Ibrutinib, acalabrutinib and zanubrutinib — They block the enzyme called Bruton’s tyrosine kinase.
- Venetoclax — It targets CLL with the BCL-2 protein.
- Idelalisib and duvelisib — They block the protein PI3K.
Some medicines can be thought of as both immunotherapies and targeted therapies — like rituximab, ofatumumab and obinutuzumab. They target the CD20 protein.
More targeted therapies are being tested and are available through clinical trials.
Immunotherapy for CLL
Immunotherapies use the power of your immune system to find and fight cancer cells.
Your hematologist-oncologist will prescribe immunotherapies and set your treatment schedule. For CLL, physicians usually use medicines called monoclonal antibodies that target CD20. CD20 is a protein on the surface of some cells, including CLL cells. These medicines include rituximab, ofatumumab and obinutuzumab. These drugs are often used along with other novel therapeutic agents.
Researchers at Fred Hutch are also studying cellular immunotherapies, such as CAR T-cell therapy, for CLL. In CAR T-cell therapy, we remove immune cells called T cells from your blood. We genetically modify them to attack cancer cells and then return them to your body.
Learn more about immunotherapy.
Blood or Marrow Transplant for CLL
A blood or marrow transplant (BMT) resets your body’s ability to make healthy blood cells. Physicians and researchers at Fred Hutch pioneered BMTs decades ago.
A small number of CLL patients may have a BMT if they have high-risk CLL that does not respond to other targeted treatments or if the disease comes back.
For CLL, physicians do a transplant using stem cells from a donor. This is called an allogeneic transplant. (For other diseases, they may use the patient’s own stem cells.) First, you get strong chemotherapy to get rid of your CLL. Then the donor’s healthy stem cells restart your body’s ability to make blood cells. Also, white blood cells from the donor may recognize any remaining CLL cells as foreign and attack them.
A team of Fred Hutch transplant experts will care for you. Your team will include a transplant oncologist, transplant nurse, physician assistant or advanced registered nurse practitioner, pharmacist, registered dietitian, team coordinator and social worker.
Our researchers continue to improve transplant techniques and to develop new options.
Learn more about blood and marrow transplants.
Monitoring Your Health During CLL Treatment
While you’re in active treatment, your CLL care team will see you regularly for exams and tests to check:
- How well your treatment is working
- If there’s any reason to change your treatment
- If you need help with side effects or supportive care services, like nutrition care or mental health counseling
We update your treatment plan based on the best scientific evidence as well as how your disease responds and what you prefer.
Possible Results of Treatment
Throughout treatment, your care team looks for signs of:
- Active disease: CLL is still present during or after treatment, or it has come back.
- Minimal residual disease: Standard tests do not find any CLL cells in your blood or bone marrow. But more sensitive tests do find some cells.
- Remission: Fewer signs and symptoms of cancer. Partial remission means there are still some signs and symptoms. Complete remission means there are no signs or symptoms.
- Relapse: The disease, signs or symptoms have come back after they had improved.
- Refractory disease: The disease does not respond to treatment.
What about “cured”? Sometimes physicians use the word “cured” if cancer has been in complete remission for at least five years. After five years, cancer is less likely to come back (recur), but recurrence is still possible. Physicians do not think of CLL as curable. Instead, the goal is to get lasting remission.
Continuing Care
When your disease is in remission and you are not on active treatment, it is still important to get follow-up care on a regular basis. At follow-up visits, you will see the same Fred Hutch team who treated your CLL. They will check your overall health and look for signs that your cancer has come back (signs of recurrence).
Your team will also help with any long-term side effects (which go on after treatment ends) or late effects (which may start after treatment is over).
For people who had a blood or marrow transplant, the Fred Hutch Long-Term Follow-Up Program provides lifelong monitoring and care.
Before you begin treatment, we talk with you about what to expect, based on your treatment plan, and what can help if you do have side effects.
At your appointments, we want you to tell us about any side effects you are having. If you have questions or concerns between appointments, you can call or email us. We will make sure you know how to reach care providers at Fred Hutch after hours, if that is when you need us.
We have many tools to help you feel better, such as:
- Antibiotics, vaccines and antiviral drugs to prevent or treat infections
- Transfusions, steroids and medicines that help the immune system to treat low levels of blood cells (low blood counts)
- Therapy to lower the number of leukemia cells (leukapheresis) to treat circulation problems or to prevent complications that may happen when targeted therapy or chemotherapy breaks down a large number of tumor cells (tumor lysis syndrome)
The Fred Hutch Patient Education team has video resources that go over how to keep common side effects at bay.
The Fred Hutch patient and family education team works with other Fred Hutch experts to create reliable resources and select materials from trusted cancer organizations. Find a resource.